Citigroup
IBB icon

Citigroup’s iShares Biotechnology ETF IBB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$515M Buy
4,073,967
+865,823
+27% +$110M 0.25% 43
2025
Q1
$410M Buy
3,208,144
+1,351,276
+73% +$173M 0.21% 55
2024
Q4
$245M Sell
1,856,868
-122,732
-6% -$16.2M 0.15% 87
2024
Q3
$288M Sell
1,979,600
-1,109,021
-36% -$161M 0.17% 75
2024
Q2
$424M Buy
3,088,621
+502,072
+19% +$68.9M 0.27% 40
2024
Q1
$355M Buy
2,586,549
+375,201
+17% +$51.5M 0.23% 44
2023
Q4
$300M Sell
2,211,348
-117,729
-5% -$16M 0.21% 41
2023
Q3
$285M Sell
2,329,077
-25,805
-1% -$3.16M 0.21% 45
2023
Q2
$299M Buy
2,354,882
+354,350
+18% +$45M 0.2% 46
2023
Q1
$258M Buy
2,000,532
+306,853
+18% +$39.6M 0.18% 56
2022
Q4
$222M Buy
1,693,679
+127,581
+8% +$16.8M 0.18% 71
2022
Q3
$183M Sell
1,566,098
-495,616
-24% -$58M 0.13% 81
2022
Q2
$243M Buy
2,061,714
+88,129
+4% +$10.4M 0.18% 59
2022
Q1
$257M Buy
1,973,585
+376,498
+24% +$49.1M 0.16% 77
2021
Q4
$244M Buy
1,597,087
+754,549
+90% +$115M 0.13% 99
2021
Q3
$136M Sell
842,538
-973,636
-54% -$157M 0.08% 157
2021
Q2
$297M Sell
1,816,174
-369,742
-17% -$60.5M 0.18% 72
2021
Q1
$329M Buy
2,185,916
+420,459
+24% +$63.3M 0.21% 61
2020
Q4
$267M Buy
1,765,457
+399,267
+29% +$60.5M 0.16% 68
2020
Q3
$185M Buy
1,366,190
+83,138
+6% +$11.3M 0.12% 84
2020
Q2
$175M Sell
1,283,052
-881,005
-41% -$120M 0.14% 76
2020
Q1
$233M Sell
2,164,057
-3,059,726
-59% -$330M 0.21% 40
2019
Q4
$630M Buy
5,223,783
+1,380,564
+36% +$166M 0.46% 12
2019
Q3
$382M Buy
3,843,219
+2,361,619
+159% +$235M 0.3% 24
2019
Q2
$162M Sell
1,481,600
-477,345
-24% -$52.1M 0.13% 87
2019
Q1
$219M Buy
1,958,945
+739,469
+61% +$82.7M 0.21% 42
2018
Q4
$118M Sell
1,219,476
-1,319,247
-52% -$127M 0.12% 85
2018
Q3
$310M Sell
2,538,723
-169,647
-6% -$20.7M 0.28% 27
2018
Q2
$297M Buy
2,708,370
+588,358
+28% +$64.6M 0.27% 31
2018
Q1
$226M Buy
2,120,012
+120,191
+6% +$12.8M 0.19% 45
2017
Q4
$214M Buy
1,999,821
+1,512,433
+310% +$161M 0.17% 57
2017
Q3
$163M Sell
487,388
-842,551
-63% -$281M 0.13% 63
2017
Q2
$412M Sell
1,329,939
-119,070
-8% -$36.9M 0.37% 12
2017
Q1
$425M Buy
1,449,009
+212,392
+17% +$62.3M 0.38% 12
2016
Q4
$328M Sell
1,236,617
-930,810
-43% -$247M 0.3% 24
2016
Q3
$627M Buy
2,167,427
+1,086,902
+101% +$315M 0.59% 4
2016
Q2
$278M Sell
1,080,525
-610,155
-36% -$157M 0.28% 26
2016
Q1
$441M Buy
1,690,680
+505,121
+43% +$132M 0.5% 9
2015
Q4
$401M Sell
1,185,559
-686,240
-37% -$232M 0.4% 10
2015
Q3
$568M Buy
1,871,799
+246,062
+15% +$74.6M 0.53% 7
2015
Q2
$600M Buy
1,625,737
+151,906
+10% +$56M 0.53% 9
2015
Q1
$506M Buy
1,473,831
+379,960
+35% +$130M 0.49% 9
2014
Q4
$332M Sell
1,093,871
-1,036,871
-49% -$315M 0.3% 17
2014
Q3
$583M Buy
2,130,742
+450,698
+27% +$123M 0.51% 9
2014
Q2
$432M Sell
1,680,044
-975,412
-37% -$251M 0.41% 16
2014
Q1
$628M Buy
2,655,456
+913,682
+52% +$216M 0.64% 9
2013
Q4
$395M Buy
1,741,774
+756,346
+77% +$172M 0.36% 16
2013
Q3
$207M Sell
985,428
-48,850
-5% -$10.2M 0.19% 45
2013
Q2
$180M Buy
+1,034,278
New +$180M 0.18% 50